Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 511

1.

Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.

Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K.

Liver Int. 2012 Jul;32(6):919-27. doi: 10.1111/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.

PMID:
22435854
2.

Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.

Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H.

J Vasc Interv Radiol. 2013 Dec;24(12):1808-16. doi: 10.1016/j.jvir.2013.08.018. Epub 2013 Oct 4.

PMID:
24099787
3.

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.

Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D.

J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.

PMID:
20932597
4.

Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.

Merola J, Fortune BE, Deng Y, Ciarleglio M, Amirbekian S, Chaudhary N, Shanbhogue A, Ayyagari R, Rodriguez-Davalos MI, Teperman L, Charles HW, Sigal SH.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):668-675. doi: 10.1097/MEG.0000000000001097.

PMID:
29462027
5.

Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.

D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI.

Transplant Proc. 2012 Nov;44(9):2603-5. doi: 10.1016/j.transproceed.2012.09.050.

PMID:
23146469
6.

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.

Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G.

Liver Int. 2016 May;36(5):667-76. doi: 10.1111/liv.12929. Epub 2015 Aug 28.

PMID:
26235541
7.

Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.

Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, Balzano A.

J Clin Gastroenterol. 2010 Jul;44(6):448-51. doi: 10.1097/MCG.0b013e3181b3ab44.

PMID:
19730112
8.

Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis.

Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, Caca K.

Dig Liver Dis. 2017 Dec;49(12):1345-1352. doi: 10.1016/j.dld.2017.05.020. Epub 2017 Jun 27.

PMID:
28733177
10.

Anticoagulation in cirrhosis.

Villa E, De Maria N.

Liver Int. 2012 Jul;32(6):878-9. doi: 10.1111/j.1478-3231.2012.02825.x. No abstract available.

PMID:
22672641
11.
12.

Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension.

Yang S, He C, Fan X, Ding W, Wu X, Li J.

J Vasc Interv Radiol. 2015 Jul;26(7):1009-17. doi: 10.1016/j.jvir.2015.03.008. Epub 2015 Apr 23.

PMID:
25921970
13.

Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.

Rosenqvist K, Eriksson LG, Rorsman F, Sangfelt P, Nyman R.

Acta Radiol. 2016 May;57(5):572-9. doi: 10.1177/0284185115595060. Epub 2015 Aug 7.

PMID:
26253926
14.

Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.

Ganger DR, Klapman JB, McDonald V, Matalon TA, Kaur S, Rosenblate H, Kane R, Saker M, Jensen DM.

Am J Gastroenterol. 1999 Mar;94(3):603-8.

PMID:
10086638
15.

Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients.

Bilbao JI, Elorz M, Vivas I, Martínez-Cuesta A, Bastarrika G, Benito A.

Cardiovasc Intervent Radiol. 2004 Sep-Oct;27(5):474-80. Epub 2004 Aug 12.

PMID:
15383850
16.

Management of portal vein thrombosis in liver cirrhosis.

Qi X, Han G, Fan D.

Nat Rev Gastroenterol Hepatol. 2014 Jul;11(7):435-46. doi: 10.1038/nrgastro.2014.36. Epub 2014 Apr 1. Review.

PMID:
24686266
17.

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.

Gîrleanu I, Trifan A, Stanciu C, Sfarti C.

World J Gastroenterol. 2018 Oct 21;24(39):4419-4427. doi: 10.3748/wjg.v24.i39.4419.

19.

Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.

Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, Tuzzolino F, Gridelli B, Bosch J.

Gut. 2011 Jun;60(6):846-52. doi: 10.1136/gut.2010.228023. Epub 2011 Feb 28.

PMID:
21357252
20.

[Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].

Han GH, Meng XJ, Yin ZX, Wang JH, He CY, Liang J, Guo XG, Liu J, Ding L, Wu KC, Fan DM.

Zhonghua Yi Xue Za Zhi. 2009 Jun 9;89(22):1549-52. Chinese.

PMID:
19953883

Supplemental Content

Support Center